Please enable Javascript
Kaitlyn D’Onofrio
Articles by Kaitlyn D’Onofrio
Cumulative Social Risk Impacts Odds of Receiving Chemotherapy
Kaitlyn D’Onofrio
Colorectal Cancer
|
August 22, 2023
An assessment of cumulative social risk may help identify patients with advanced colorectal cancer (CRC) who are less ...
Read More
Phase 2 KEYNOTE-799 Trial: Pembrolizumab Plus cCRT Safe, Effective in NSCLC
Kaitlyn D’Onofrio
Non-Small Cell Lung Cancer
|
September 21, 2023
Treatment with pembrolizumab plus concurrent chemoradiation therapy (cCRT) was safe and effective in patients with ...
Read More
Should Patients Wait to Undergo Surgery for Early-Stage Lung Cancer?
Kaitlyn D’Onofrio
Non-Small Cell Lung Cancer
|
September 21, 2023
Patients with early-stage non-small cell lung cancer (NSCLC) should not delay undergoing surgery, as waiting too long ...
Read More
A 10-year Analysis of Survival in Pulmonary Arterial Hypertension With Versus Without Associated Connective Tissue Disease
Kaitlyn D’Onofrio
Hypertension
|
May 2, 2023
Although patients with connective tissue disease (CTD)-associated pulmonary arterial hypertension (PAH) have a higher ...
Read More
Gender Roles May Affect the Experiences of Men and Women Living With Mesothelioma
Kaitlyn D’Onofrio
Mesothelioma
|
September 21, 2023
Men and women living with mesothelioma may share similar experiences but have different concerns that nurses and other ...
Read More
Mifamurtide Added to Osteosarcoma Therapy May Improve Outcomes
Kaitlyn D’Onofrio
Oncology
|
November 27, 2024
The addition of mifamurtide to conventional therapy improved progression-free survival (PFS) in patients with ...
Read More
Risk Factors for VTE in Patients with Psoriasis, Psoriatic Arthritis
Kaitlyn D’Onofrio
VTE
|
August 29, 2023
A study analyzed the prevalence of and risk factors for venous thromboembolism (VTE) in patients with psoriasis and ...
Read More
Aprepitant Effective in Reducing Nausea from Chemo in Women
Kaitlyn D’Onofrio
GI Cancer
|
August 22, 2023
The addition of aprepitant to a regimen to reduce chemotherapy-induced nausea among women was effective in a recent ...
Read More
Hydroxychloroquine Improves Vascular Outcomes in Patients with Systemic Lupus Erythematosus
Kaitlyn D’Onofrio
Thrombosis
|
September 6, 2023
Patients with systemic lupus erythematosus (SLE) taking hydroxychloroquine may also benefit from improved vascular ...
Read More
Tofacitinib Under Review for Heart-related Issues, Cancer in Canada Months after FDA Announcement
Kaitlyn D’Onofrio
Rheumatoid Arthritis
|
May 2, 2023
Health Canada is conducting a safety review into tofacitinib following reports that the drug may be associated with ...
Read More
Can Gastric Cancer Be Detected by a Breath Analyzer?
Kaitlyn D’Onofrio
Gastric Cancer
|
August 21, 2023
A breath analyzer may be able to identify gastric cancer, a study discovered. ...
Read More
Memantine Does Not Improve MS Fatigue
Kaitlyn D’Onofrio
Multiple Sclerosis
|
August 1, 2023
A systematic review and meta-analysis did not find enough evidence to support the use of memantine in patients with ...
Read More
Survival After Hip Fracture Surgery May Depend On How Busy The Hospital Is
Kaitlyn D’Onofrio
Orthopedics
|
September 12, 2023
Patients with hip fracture who are admitted to the hospital during a busy time may experience delayed surgery and have a ...
Read More
Unmarried, Low Education Tied To Lower Odds of Transplantation in Mantle Cell Lymphoma
Kaitlyn D’Onofrio
Oncology
|
July 5, 2023
Patients with mantle cell lymphoma who are unmarried, have a lower educational level, or with multiple comorbidities are ...
Read More
Long-term Risk of Frailty in Survivors of Blood or Bone Marrow Transplantation
Kaitlyn D’Onofrio
Oncology
|
July 5, 2023
A study examined longitudinal trends in the frailty state of blood or bone marrow transplantation (BMT) survivors. The ...
Read More
Adalimumab Versus Biosimilar: How Do These Drugs Compare in RA, PsA, PsO?
Kaitlyn D’Onofrio
Psoriasis
|
May 2, 2023
An analysis of two studies comparing adalimumab biosimilar SDZ-ADL versus reference adalimumab in patient-reported ...
Read More
Artificial Intelligence Decision Aid A Significant Benefit For Patients with OA Considering Knee Replacement
Kaitlyn D’Onofrio
AI
|
August 1, 2023
Patients with osteoarthritis (OA) of the knee who are thinking of undergoing total knee replacement (TKR) may benefit ...
Read More
Dustin Diamond Dead From Lung Cancer at 44. What Is the Prognosis for SCLC?
Kaitlyn D’Onofrio
Small Cell Lung Cancer
|
September 21, 2023
Dustin Diamond, who rose to fame in the 1990s for his role as Samuel “Screech” Powers on the hit television show ...
Read More
Did Dustin Diamond Get Lung Cancer From Staying in Cheap Motels?
Kaitlyn D’Onofrio
Small Cell Lung Cancer
|
September 21, 2023
Dustin Diamond is questioning what caused him to develop lung cancer and is reportedly speculating whether it may be the ...
Read More
Dustin Diamond, Known As Screech on ‘Saved By The Bell,’ Starts Stage 4 Lung Cancer Treatment—What Does This Mean?
Kaitlyn D’Onofrio
Small Cell Lung Cancer
|
September 21, 2023
Dustin Diamond, known best for his portrayal of Screech Powers on the hit 1990’s show “Saved By The Bell,” was ...
Read More
Load More